Lyu Z H, Xu W, Ma J K, Feng S H, Jing P H, Liu X L, Zhou C
Department of Head and Neck Surgery, Shandong Provincial ENT Hospital, Jinan 250023, China.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2023 Jun 7;58(6):558-564. doi: 10.3760/cma.j.cn115330-20221201-00724.
To retrospectively analyse the efficacy of surgerical comprehensive treatment for hypopharyngeal cancer. Four hundred and fifty-six cases of hypopharyngeal squamous cell carcinoma treated from Jan 2014 to Dec 2019 were analyzed retrospectively, including 432 males and 24 females, aged 37-82 years old. There were 328 cases of pyriform sinus carcinoma, 88 cases of posterior pharyngeal wall carcinoma, and 40 cases of postcricoid carcinoma. According to American Joint Committe on Cancer(AJCC) 2018 criteria, 420 cases were of stage Ⅲ or Ⅳ; 325 cases were of T3 or T4 stage. Treatment methods included surgery alone in 84 cases, preoperative planned radiotherapy plus surgery in 49 cases, surgery plus adjuvant radiotherapy or concurrent chemoradiotherapy in 314 cases, and inductive chemotherapy plus surgery and adjuvant radiotherapy in 9 cases. The primary tumor resection methods included transoral laser surgery in 5 cases, partial laryngopharyngectomy in 74 cases, of them 48 cases (64.9%) presented with supracricoid hemilaryngopharyngectomy, total laryngectomy with patial pharyngectomy in 90 cases, total laryngopharyngectomy or with cervical esophagectomy in 226 cases, and total laryngopharyngectomy with total esophagectomy in 61 cases. Among 456 cases, 226 cases received reconstruction surgery with free jejunum transplantation, 61 cases with gastric pull-up, and 32 cases with pectoralis myocutaneous flaps. All patients underwent retropharyngeal lymph node dissection, and high-definition gastroscopy was performed during admission and follow-up. SPSS 24.0 software was used to analyze the data. The 3-year and 5-year overall survival rates were respectively 59.8%, and 49.5%. The 3-year and 5-year disease specific survival rates were respectively 69.0% and 58.8%. Total metastasis rate of retropharyngeal lymph nodes was 12.7%. A total of 132 patients (28.9%) suffered from simultaneous and metachronous multiple primary carcinoma of the hypopharynx. Multivariate Logistic regression analysis showed that T3-4 disease, cervical lymph node metastasis, retropharyngeal lymph node metastasis and postoperative adjuvant radiotherapy were independent factors affecting the prognosis of patients (all <0.05). As of April 30, 2022, a total of 221 patients died during follow-up, of 109 (49.3%) with distant metastases, which were the main cause of death. The efficacy of comprehensive treatment for hypopharyngeal cancer can be improved by accurate preoperative evaluation, improved surgical resection, active retropharyngeal lymph node dissection and full process intervention of the second primary cancer.
回顾性分析下咽癌手术综合治疗的疗效。回顾性分析2014年1月至2019年12月收治的456例下咽鳞状细胞癌患者,其中男性432例,女性24例,年龄37 - 82岁。梨状窝癌328例,下咽后壁癌88例,环状软骨后癌40例。根据美国癌症联合委员会(AJCC)2018年标准,Ⅲ期或Ⅳ期420例;T3或T4期325例。治疗方法包括单纯手术84例,术前计划性放疗加手术49例,手术加辅助放疗或同步放化疗314例,诱导化疗加手术及辅助放疗9例。原发肿瘤切除方法包括经口激光手术5例,部分喉咽切除术74例,其中48例(64.9%)为环状软骨上半喉咽切除术,全喉切除加部分下咽切除术90例,全喉咽切除术或加颈段食管切除术226例,全喉咽切除术加全食管切除术61例。456例患者中,226例行游离空肠移植重建手术,61例行胃上提术,32例行胸大肌肌皮瓣修复术。所有患者均行咽后淋巴结清扫术,入院及随访期间行高清胃镜检查。采用SPSS 24.0软件进行数据分析。3年和5年总生存率分别为59.8%和49.5%。3年和5年疾病特异性生存率分别为69.0%和58.8%。咽后淋巴结总转移率为12.7%。共有132例患者(28.9%)发生同时性和异时性下咽多原发癌。多因素Logistic回归分析显示,T3 - 4期病变、颈部淋巴结转移、咽后淋巴结转移及术后辅助放疗是影响患者预后的独立因素(均P<0.05)。截至2022年4月30日,随访期间共有221例患者死亡,其中109例(49.3%)死于远处转移,是主要死亡原因。准确的术前评估、改进手术切除、积极的咽后淋巴结清扫及对第二原发癌的全程干预可提高下咽癌综合治疗的疗效。